These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7360294)

  • 1. [An epidemiological study of risk indicators for cardiovascular diseases (EPOZ). II. Incidence, case finding and treatment of hypertension in an open population].
    Hofman A; Valkenburg HA
    Ned Tijdschr Geneeskd; 1980 Feb; 124(6):189-95. PubMed ID: 7360294
    [No Abstract]   [Full Text] [Related]  

  • 2. [An epidemiological study of risk indicators for cardiovascular diseases (EPOZ). I. Blood pressure, serum cholesterol level, Quetelet-index and smoking habits in an open population aged 5 years and older].
    Valkenburg HA; Hofman A; Klein F; Groustra FN
    Ned Tijdschr Geneeskd; 1980 Feb; 124(6):183-9. PubMed ID: 7360293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevalence, case-finding and treatment of hypertension in Lelystad (1982-1984); is the 'rule of halves' still applicable?].
    van Loo JM; Drenthen AJ; Peer PG; Thien TA
    Ned Tijdschr Geneeskd; 1987 Apr; 131(15):624-7. PubMed ID: 3574532
    [No Abstract]   [Full Text] [Related]  

  • 4. [Instead of endless discussions on what constitutes optimal treatment of hypertension--identify and treat at-risk patients].
    Füessl HS
    MMW Fortschr Med; 2005 Mar; 147(13):29. PubMed ID: 15832757
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac care. 2001 Canadian hypertension recommendations.
    Canadian Hypertension Recommendations Working Group
    Can Nurse; 2002 Jun; 98(6):17-21. PubMed ID: 12098851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension among very elderly].
    Strandberg T
    Duodecim; 2005; 121(13):1421-6. PubMed ID: 16134715
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of cardiovascular risk factors on prescribing of antihypertensives].
    Vaur L; Amar J; Perret M; Bailleau C; Etienne S; Chamontin B
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):846-50. PubMed ID: 11575216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender and the response to blood pressure-lowering treatment.
    Lip GY; Butt M
    Eur Heart J; 2008 Nov; 29(21):2585-6. PubMed ID: 18852182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Should simple-to-moderate hypertension in the aged be treated?].
    Christensen HR; Svendsen TL; Hansen JM; Kampmann JP
    Ugeskr Laeger; 1984 Apr; 146(18):1376-8. PubMed ID: 6495419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular risk profile and anti-hypertensive treatment].
    Olsen MH; Sehestedt T; Prescott E
    Ugeskr Laeger; 2009 Jun; 171(24):2008-11. PubMed ID: 19523363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional CVD risk factors and socio-economic deprivation in Roma minority population of Croatia.
    Zeljko H; Skarić-Jurić T; Narancic NS; Salihović MP; Klarić IM; Barbalić M; Starcević B; Lauc LB; Janićijević B
    Coll Antropol; 2008 Sep; 32(3):667-76. PubMed ID: 18982735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 13. [European Hypertension Congress initiative: implement modern risk management without further delay!].
    Aumiller J
    MMW Fortschr Med; 2005 Sep; 147(38):39, 41-2. PubMed ID: 16218227
    [No Abstract]   [Full Text] [Related]  

  • 14. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.
    Fossum E; Gleim GW; Kjeldsen SE; Kizer JR; Julius S; Devereux RB; Brady WE; Hille DA; Lyle PA; Dahlöf B
    J Intern Med; 2007 Oct; 262(4):439-48. PubMed ID: 17875180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension in dialysis: pathophysiology and treatment.
    D'Amico M; Locatelli F
    J Nephrol; 2002; 15(4):438-45. PubMed ID: 12243377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood pressure limits for beginning and goal of antihypertensive therapy (3). What is not proven but plausible?].
    Holzgreve H
    MMW Fortschr Med; 2005 Jul; 147(27-28):39-40. PubMed ID: 16041940
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case findings and guidance of hypertensive patients; a task for the family practitioner].
    Van der Feen AE
    Ned Tijdschr Geneeskd; 1978 May; 122(21):754-9. PubMed ID: 652089
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetic hypertension.
    Khan KA; Govindarajan G; Whaley-Connell A; Sowers JR
    Heart Fail Clin; 2006 Jan; 2(1):25-36. PubMed ID: 17386874
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.